Danaher (NYSE:DHR) Shares Acquired Rep. Julie Johnson

Representative Julie Johnson (D-Texas) recently bought shares of Danaher Corporation (NYSE:DHR). In a filing disclosed on November 14th, the Representative disclosed that they had bought between $1,001 and $15,000 in Danaher stock on October 7th. The trade occurred in the Representative’s “CHASE BROKERAGE ACCOUNT (3935)” account.

Representative Julie Johnson also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 10/31/2025.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/31/2025.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/27/2025.
• Sold $1,001 – $15,000 in shares of Deere & Company (NYSE:DE) on 10/22/2025.
• Sold $1,001 – $15,000 in shares of Alaska Air Group (NYSE:ALK) on 10/22/2025.
• Sold $1,001 – $15,000 in shares of Weyerhaeuser (NYSE:WY) on 10/22/2025.
• Sold $1,001 – $15,000 in shares of F5 (NASDAQ:FFIV) on 10/22/2025.
• Sold $1,001 – $15,000 in shares of Gen Digital (NASDAQ:GEN) on 10/22/2025.
• Sold $1,001 – $15,000 in shares of The PNC Financial Services Group (NYSE:PNC) on 10/21/2025.
• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 10/21/2025.

Danaher Trading Up 2.3%

Danaher stock traded up $5.16 during trading hours on Friday, hitting $227.34. The company had a trading volume of 3,181,258 shares, compared to its average volume of 4,192,471. The firm has a market cap of $160.58 billion, a P/E ratio of 46.88, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a 50-day moving average price of $208.58 and a two-hundred day moving average price of $202.05. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the previous year, the firm posted $1.71 earnings per share. The company’s revenue was up 4.4% on a year-over-year basis. On average, sell-side analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were given a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend was Friday, September 26th. Danaher’s payout ratio is 26.39%.

Insider Buying and Selling at Danaher

In other Danaher news, SVP Georgeann Couchara sold 5,174 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. The trade was a 59.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 30,248 shares of company stock worth $6,609,663. 11.10% of the stock is owned by insiders.

Institutional Trading of Danaher

Institutional investors have recently modified their holdings of the company. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter valued at approximately $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter valued at $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher during the 2nd quarter valued at $27,000. ANTIPODES PARTNERS Ltd purchased a new position in Danaher during the 3rd quarter worth $27,000. Finally, TruNorth Capital Management LLC purchased a new position in Danaher during the 3rd quarter worth $28,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

DHR has been the subject of several research reports. Bank of America lowered their target price on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Royal Bank Of Canada set a $241.00 price objective on Danaher in a report on Tuesday, September 2nd. Redburn Partners set a $220.00 target price on shares of Danaher in a report on Wednesday, October 8th. Rothschild Redb downgraded shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Finally, Barclays upped their price target on shares of Danaher from $225.00 to $250.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Eighteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and an average target price of $243.39.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.